With pressure to lower prescription prices and drugmakers partnering with more telehealth platforms to broaden access, the number of Americans on GLP-1 medication is expected to rise
Survodutide is a dual GLP-1/glucagon receptor agonist showing promising results in clinical trials
Drought is considered one of the most severe environmental stresses due to unpredictable factors such as fluctuating temperature dynamics, light intensity, and undependable rainfall (Seleiman et al., 2021)
While Regeneron is far from the first to buy a GLP-1 pipeline, its bullish on Hansohs formula due to its testing in China
Its clean hormonal profile makes it ideal for bedtime dosing to augment the nocturnal GH surge
In animal models exposed to amphetamine or haloperidol, investigators observed that the peptide appeared to reduce behavioral changes associated with altered dopamine activity